Ubs Group Ag Bio Techne Corp Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Bio Techne Corp stock. As of the latest transaction made, Ubs Group Ag holds 276,346 shares of TECH stock, worth $19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

276,346

Previous 246,063 12.31%

Holding current value

$19 Million

Previous $17.6 Million 25.25%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $2.15 Million - $2.49 Million	30,283 Added 12.31%	276,346 $22.1 Million
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $2.15 Million - $2.92 Million	34,643 Added 16.39%	246,063 $17.6 Million
Q1 2024 May 13, 2024	BUY	$65.98 - $77.09 $4.52 Million - $5.28 Million	68,471 Added 47.9%	211,420 $14.9 Million
Q4 2023 Feb 09, 2024	BUY	$52.83 - $78.22 $6.06 Million - $8.97 Million	114,648 Added 405.1%	142,949 $11 Million
Q3 2023 Nov 09, 2023	SELL	$67.52 - $89.42 $399,718 - $529,366	-5,920 Reduced 17.3%	28,301 $1.93 Million
Q2 2023 Aug 11, 2023	BUY	$73.76 - $85.98 $441,453 - $514,590	5,985 Added 21.2%	34,221 $2.79 Million
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $67,680 - $81,855	945 Added 3.46%	28,236 $2.09 Million
Q4 2022 Feb 08, 2023	BUY	$80.67 - $352.29 $1.67 Million - $7.29 Million	20,699 Added 314.0%	27,291 $2.26 Million
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $326,616 - $452,978	-1,156 Reduced 14.92%	6,592 $1.87 Million
Q2 2022 Aug 10, 2022	SELL	$322.67 - $449.65 $2.31 Million - $3.22 Million	-7,163 Reduced 48.04%	7,748 $2.69 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $4.77 Million - $6.57 Million	-13,472 Reduced 47.47%	14,911 $6.46 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $520,923 - $599,618	1,142 Added 4.19%	28,383 $14.7 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $2.26 Million - $2.74 Million	5,083 Added 22.94%	27,241 $13.2 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $275,793 - $320,585	-712 Reduced 3.11%	22,158 $9.98 Million
Q1 2021 May 12, 2021	BUY	$314.62 - $411.0 $209,851 - $274,137	667 Added 3.0%	22,870 $8.74 Million
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $507,132 - $661,120	2,054 Added 10.19%	22,203 $7.05 Million
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $3.91 Million - $4.77 Million	16,856 Added 511.87%	20,149 $4.99 Million
Q2 2020 Jul 31, 2020	SELL	$185.43 - $279.56 $349,350 - $526,691	-1,884 Reduced 36.39%	3,293 $869,000
Q1 2020 May 01, 2020	SELL	$161.17 - $221.51 $5.83 Million - $8.01 Million	-36,158 Reduced 87.48%	5,177 $982,000
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $4.28 Million - $5.01 Million	22,572 Added 120.3%	41,335 $9.07 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $2.61 Million - $3.08 Million	14,211 Added 312.19%	18,763 $3.67 Million
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $211,743 - $241,712	-1,122 Reduced 19.77%	4,552 $950,000
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $89,955 - $132,490	661 Added 13.19%	5,674 $1.13 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $679,547 - $1.04 Million	-5,119 Reduced 50.52%	5,013 $726,000
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $250,942 - $347,395	1,702 Added 20.19%	10,132 $2.07 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $1.51 Million - $1.73 Million	-10,440 Reduced 55.33%	8,430 $1.25 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $1.01 Million - $1.16 Million	7,690 Added 68.78%	18,870 $2.85 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $609,606 - $677,927	-5,031 Reduced 31.03%	11,180 $1.45 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $1.22 Million - $1.33 Million	10,714 Added 194.91%	16,211 $1.96 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-661 Reduced 10.73%	5,497 $645,000
Q1 2017 Nov 14, 2017	BUY	N/A	6,158	6,158 $626,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account